HOME > TOP STORIES

TOP STORIES

BUSINESS Open Tenders Good Example of Early Price Settlements: Qol Exec

January 22, 2015
ORGANIZATION Some LDP Members Keen to Tackle Kampo NHI Price Problem

January 21, 2015
REGULATORY R&D Tax Credit Revamp (2): No Deadline Set, yet Revision Could Come Up for Debate towards FY2017

January 21, 2015
REGULATORY R&D Tax Credit Revamp (1): New Scheme for Open Innovation Research Significant in 3 Ways

January 20, 2015
REGULATORY PMDA Head Expresses Full Support for AMED

January 19, 2015
ORGANIZATION JPMA Notifies of Unfavorable Expressions for Disease Awareness Ads

January 16, 2015
ORGANIZATION Pharma Leader Nakayama Hails Tax Plan, Says His New Year Remarks Misleading

January 15, 2015
INTERVIEW EFPIA Japan Chairman Says Drug Costs Won’t Explode

January 14, 2015
ORGANIZATION Wholesalers Must Revamp Biz Model to Cope with Change in Sales Mix: JPWA Chief

January 14, 2015
REGULATORY MHLW Calls for Revision of Package Inserts for SGLT-2 Inhibitors

January 13, 2015
ORGANIZATION Price Grouping Rule Triggered “Distortion” in Generic Market: JGA President

January 9, 2015
REGULATORY 30% R&D Tax Deduction Cap Could Be Secured with Open Innovation Tax Break: Economic Affairs Division

January 8, 2015
REGULATORY Public Trust Indispensable for Industry Development: Mr Futagawa of Health Policy Bureau

January 7, 2015
REGULATORY Pharmaceutical and Food Safety Bureau to Promote Prescription-to-OTC Switches Based on Industry Opinions

January 6, 2015
ORGANIZATION FPMAJ Chairman Wishes for Good Environment for Drug Innovation in 2015

January 1, 2015
TRENDS ARBs at a Turning Point: Inroads by Generics to Lead to Gradual Decline in Sales

December 26, 2014
REGULATORY LDP Study Group Shows Sense of Crisis over Reduction of R&D Tax Deduction Cap

December 25, 2014
ORGANIZATION FPMAJ “Hasn’t Given Up” on Maintenance of 30% R&D Tax Deduction Cap: Chairman

December 24, 2014
ORGANIZATION EFPIA Japan Chairman Calls for More Rewards for Innovation

December 22, 2014
BUSINESS Takeda Names Sanofi’s Plump as New R&D Head

December 19, 2014

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?

Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…